
Quris is a pioneering artificial intelligence innovator that is revolutionizing the drug development process. The Bio AI Clinical Prediction Platform developed by Quris excels in predicting which drug candidates will safely work on humans, thereby averting the substantial costs associated with clinical trials. This platform facilitates efficient drug discovery, along with the repurposing and personalization of existing drugs. Guided by a team of leading scientists and supported by strategic investors, the company is actively preparing for clinical testing with its first AI-based drug.
Within the pharmaceutical domain, executives are actively seeking ways to unlock the capabilities of artificial intelligence within both healthcare and the biotech sectors. Reports reveal a growing apperception of the potential and the practical applications currently in use, propelling the industry towards a digitally-driven future. According to estimates by McKinsey Global Institute, the incorporation of AI and machine learning in the pharmaceutical sector could generate nearly US$100 billion annually throughout the US healthcare system.